key: cord-0707913-72cxzzn3 authors: Mileto, Davide; Foschi, Antonella; Mancon, Alessandro; Merli, Stefania; Staurenghi, Federica; Pezzati, Laura; Rizzo, Alberto; Conti, Federico; Romeri, Francesca; Bernacchia, Dario; Meroni, Rachele; Rizzardini, Giuliano; Gismondo, Maria Rita; Micheli, Valeria title: A case of extremely prolonged viral shedding: could cell cultures be a diagnostic tool to drive the COVID-19 patients discharge? date: 2020-11-20 journal: Int J Infect Dis DOI: 10.1016/j.ijid.2020.11.161 sha: e819b6aa6a74c05259d2758a21371ba4092a50e5 doc_id: 707913 cord_uid: 72cxzzn3 This study addresses the case of a patient with prolonged viral shedding reported by Real-Time PCR, until 71 days from symptoms onset. However, viral culture got negative results after 30 days from symptoms onset. Viral culture may thus be a worthwhile test for patients discharge, in particular for those presenting prolonged viral shedding. found that male gender, delayed hospitalization and mechanical ventilation are factors independently associated with a prolonged viral shedding. It is unclear whether patients with prolonged viral shedding may infect other people since data on in-vitro replication of the virus in this population are lacking. We report the case of a patient with persistently positive SARS-CoV-2 nasopharyngeal swabs (NPS), which were all used for viral isolation in cell culture. The patient was an 84-year-old man, with a history of COPD, valvulopathy, atrial fibrillation in treatment with acenocoumarol and prostatic cancer in treatment with bicalutamide; he had been vaccinated against Influenza. He presented at the Emergency Room Department on the 26 February, 2020 lamenting dyspnoea and dry cough since the 20 February; after the diagnosis of SARS-CoV-2 related pneumonia, the patient was admitted to our Infectious Disease ward. Upon admission lung auscultation revealed diminished vesicular breath sounds with rales on the lower left lung. Low-flow oxygen was administered due to poor peripheral oxygen saturation levels. No deterioration of neurological status was observed. After obtaining informed consent we started antiviral therapy with lopinavir/ritonavir and hydroxychloroquine (Chakraborty C et al., 2020) ; the patient also received a seven-day course of ceftriaxone and a five-day course of azithromycin since community acquired pneumonia could not J o u r n a l P r e -p r o o f be ruled out. We switched from acenocoumarol to fondaparinux to avoid potential drug-drug interactions. C-reactive protein (CRP) gradually decreased (from 183 to 29 mg/L) and chest X-ray improved during hospitalization. As of 15 March, the patient was asymptomatic, didn't need oxygen therapy and had a respiratory rate under 22 acts per minute. Therefore, he was considered clinically recovered. Given the patient's advanced age, many comorbidities and need of assistance and since nursing homes could not accept people infected with SARS-CoV-2, we opted for him to stay in hospital until he could be declared not infective (i.e. after 14 days from clinical recovery and two negative NPSs Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility SARS-CoV-2 causing pneumonia-associated respiratory disorder (COVID-19): diagnostic and proposed therapeutic options Detectable serum SARS-CoV-2 viral load (RNAaemia) is closely correlated with drastically elevated interleukin 6 (IL-6) level in critically ill COVID-19 patients Italian Ministry of Health. Civil Protection Department Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards Case Report: Viral Shedding for 60 Days in a Woman with COVID-19 Prolonged virus shedding even after seroconversion in a patient with COVID-19 Duration of SARS-CoV-2 viral shedding during COVID-19 infection SARS-CoV-2: The viral shedding vs infectivity dilemma Virological assessment of hospitalized patients with COVID-2019 World Health Organization. WHO Coronavirus Disease (COVID-19) Dashboard Factors associated with prolonged viral RNA shedding in patients with Coronavirus Disease 2019 (COVID-19) Prolonged Viral RNA Shedding Duration in COVID-19 Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Table 1. The table shows the data of the 14 nasopharyngeal swabs collected from 02 The molecular analysis has been performed using a three target gene Real-Time PCR The presence of cytopathic effect on cell culture (Positive) provided evidence of viable virus. The two last swabs have not been tested with because of negative Real-Time PCR results NPS: nasopharyngeal swab; RdRp: RNA-dependent RNA polymerase